Chief Technology Officer Jay S Stout sold $75K of Immunovant, Inc.

Sold$75,099

$28.94Price

2,595Shares

−1%Stake

What IMVT did after the filing

Prices for IMVT after this filing aren't in yet.

Traded Wed, Oct 21. Filed Fri, Oct 23, 4:55 PM ET, after the close. Not investment advice.